This content is machine translated Atopic dermatitis: system therapy Patient-centered care as the key to successful treatment The therapeutic landscape in the field of atopic dermatitis is changing. The spectrum of biologics and JAK inhibitors has expanded. Study data attest to the high efficacy of all currently…
View Post 4 min This content is machine translated Prevention strategies Addressing asthma symptoms in children at an early stage Asthma-like symptoms are common in early childhood and are often the reason for hospitalization, especially in young children. There are many risk factors for such an occurrence – approaches to…
View Post 5 min This content is machine translated Moderate to severe atopic dermatitis Itching is an immense stress factor Numerous studies show that moderate or severe atopic dermatitis, if inadequately controlled symptomatically, results in a significant “burden of disease” and can have a negative impact on the lives of…
View Post 4 min This content is machine translated Allergic rhinitis and allergen immunotherapy Recommendation update and new therapeutic approach Allergic rhinitis (AR) is still often trivialized, but there is no reason for this: It is a major chronic respiratory disease with high prevalence and impact on quality of life,…
View Post 2 min This content is machine translated GINA Report 2022 One more biologics arrow in the quiver In last year’s update, the Global Initiative for Asthma (GINA) had established two pathways (tracks) that can be followed to treat bronchial asthma. The 2022 GINA update has remained faithful…
View Post 4 min This content is machine translated Exogenous allergic alveolitis Turtled out with the pigeons A 53-year-old man has been suffering from slowly increasing respiratory symptoms such as cough, chest tightness to shortness of breath for several years. While they initially manifested themselves only after…
View Post 6 min This content is machine translated Atopic dermatitis Modern systems therapeutics specifically regulate the excessive immune response The therapeutic landscape for patients with moderate to severe atopic dermatitis is changing. In the multifactorial pathogenesis of this chronic recurrent dermatosis, an impaired immune response plays a central role.…
View Post 3 min This content is machine translated COPD in kidney smokers Lung sick despite abstinence Traditionally, tobacco smoke has been considered the classic trigger for chronic obstructive pulmonary disease (COPD). But about half of all COPD cases worldwide are due to non-tobacco-related risk factors. An…
View Post 5 min This content is machine translated Epidemiological study Dermatophyte infections in children and adults A German research team evaluated the findings of mycological dermatophyte cultures according to identified pathogen, clinical picture, and sociodemographic factors in a retrospective multicenter study. The 2021 in the Journal…
View Post 5 min This content is machine translated Atopic dermatitis Tralokinumab – another biologic with an excellent benefit-risk profile Since the beginning of June this year, tralokinumab – a human monoclonal IgG4 antibody that specifically binds with high affinity to the cytokine IL-13 – has been approved for adults…
View Post 4 min This content is machine translated Hidradenitis suppurativa: study report Successful treatment demonstrably improves quality of life Adalimumab (anti-TNF-α) is currently still the only approved biologic for the treatment of moderate to severe hidradenitis suppurativa (HS). In a recent “real world” 52-week study, treatment with adalimumab resulted…
